Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide in Acute Ischemic Stroke (BAST)
NCT03539445Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jul 2018
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of butylphthalide in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Jul 2018; status: completed.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03539445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03539445.